Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

U.S. Reps. Raja Krishnamoorthi, D-Ill., and Earl “Buddy” Carter, R-Ga., along with nine other representatives, introduced a ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...

The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...

But even as we were horrified at the tragedies and grieved the loss of life, we were also grateful to read media reports about how corporations, nonprofits, and government entities rose to the ...

The State Health Plan has halted contract negotiations with CVS Caremark over what the agency is calling a refusal to honor current obligations for its pharmacy benefit manager services.

Drugs like semaglutide, also known by the brand names Ozempic and Wegovy, have transformed how we treat obesity, but soaring demand has led to frequent supply shortages. In the US ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Opinion: Miami attorney Gregg Goldfarb says wielding antitrust, fraud, and nuisance claims can help attorneys score wins in ...